<DOC>
	<DOCNO>NCT00187200</DOCNO>
	<brief_summary>The purpose study evaluate benefit interventricular ( V-V ) delay optimization reduce non-responder rate patient cardiac resynchronization defibrillator ( CRT-D ) device . The primary endpoint study CRT responder rate . For patient enrolled new CRT-D system , patient consider non-responders BOTH follow requirement fulfil : - &lt; 10 % improvement 6-minute hall walk , - class improvement worsen New York Heart Association ( NYHA ) scale . For receive CRT-D device replacement old CRT-D system , patient consider non-responders BOTH follow requirement fulfil : - &gt; 1 heart failure ( HF ) relate hospitalization , - class improvement worsen NYHA scale .</brief_summary>
	<brief_title>Response Cardiac Resynchronization Therapy Optimization With Ventricle Ventricle Timing Heart Failure Patients</brief_title>
	<detailed_description>Study Methods - This prospective , randomize ( simultaneous biventricular ( BiV ) pace vs. sequential BiV pacing ) study . - Any patient receives FDA approve St. Jude Medical ( SJM ) CRT-D V-V timing eligible enrollment . - At 3 month post enrollment ( implant CRT-D replacement ) , patient screen non-responders randomize either simultaneous sequential BiV pacing . Patients require replacement CRT-D device identify non-responders CRT enrol screening/randomization visit . - Patients follow period 6 month post randomization : - Enrollment ( 1 week pre CRT-D implant &lt; 2 week post CRT-D implant ) - Screening/Randomization Visit ( 3 month post enrollment ) - Follow-up Visit ( 6 month post randomization ) - Total # center - 80 center - Sample size - 800 patient screen CRT non-responders</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient standard indication CRTD . Patient ability complete 6minute hall walk limit factor fatigue shortness breath . Patient geographically stable willing comply require followup schedule . Prior 1 month randomization , patient 's HF medication maintain stable remain stable throughout study . Patients require CRTD replacement must comply BOTH follow : &gt; 1 HF related hospitalization No class improvement worsen NYHA scale Patient 's life expectancy le 12 month . Patient cardiac surgery within 6 month enrollment . Patient epicardial ventricular lead system . Patient le 18 year old . Patient pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>